Atopix Therapeutics Alternatives & Competitors
12 companies similar to Atopix Therapeutics — Pioneering new frontiers in allergy treatment with breakthrough CRTH2 antagonist...
Companies similar to Atopix Therapeutics
Third Harmonic Bio
Advancing the next wave of medicine for inflammatory diseases
San Francisco, United Sta...
Clarus Therapeutics
Driven by a mission to help men overcome the health-eroding symptoms of hypogonadism
DiscGenics
REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN
Salt Lake City, United St...
Shattuck Labs
Expanding the Boundaries of Biologic Medicines
Austin, United States
Rival Readout
Competing with Atopix Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Noveome Biotherapeutics, Inc.
Transforming the way challenging diseases and conditions are treated.
Pittsburgh, United States
Pardes Biosciences
On a mission to tackle pandemic-sized challenges with innovative, oral antiviral treatment...
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
Quercis Pharma
For a Healthier World
Zug, Switzerland
Oxurion NV
Advancing Science. Enhancing Vision
Leuven, Belgium
Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...
Basel, Switzerland
Linio Biotech
Redefining skin regeneration
Helsinki, Finland
About Atopix Therapeutics
Atopix Therapeutics is a UK-based biopharmaceutical company founded in 2012, with a focus on revolutionizing allergy treatment through the development of CRTH2 antagonists. The company's lead candidate, currently in a Phase 2 clinical trial for atopic dermatitis, has garnered significant attention and secured a Venture...
Biopharmaceutical Company, Allergy Treatment, CRTH2 Antagonists, Atopic Dermatitis, Asthma Treatment, Allergic Rhinitis, Clinical-stage, Pharmaceutical Research, Innovative Medicine, Clinical Trial, Oxford, UK, Private Company, European Dermatology Centers
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Atopix Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Atopix Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
